https://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.png00BBC Newshttps://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.pngBBC News2024-10-20 09:37:052024-10-20 11:18:38Cyclist Sir Chris Hoy announces his cancer is terminal
BBC NewsWe’ve spent years covering the Lucy Letby case – here’s why experts are still arguing about it
For more than a year, we’ve been examining the scientific evidence and speaking to the experts at the centre of the case.
https://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.png00BBC Newshttps://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.pngBBC News2024-10-20 03:49:472024-10-20 03:49:47We’ve spent years covering the Lucy Letby case – here’s why experts are still arguing about it
BBC NewsHow will weight-loss drugs change our relationship with food?
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.
https://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.png00BBC Newshttps://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.pngBBC News2024-10-18 00:39:282024-10-18 00:39:28Breast cancer patients denied life-extending drug in cost row
BBC NewsBreast cancer patients denied life-extending drug in cost row
Jeannie Ambrose, one of about 1,000 affected patients, says the drug should be made available on the NHS
https://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.png00BBC Newshttps://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.pngBBC News2024-10-18 00:39:282024-10-18 00:39:28Breast cancer patients denied life-extending drug in cost row
BBC NewsBreast cancer patients denied life-extending drug in cost row
Jeannie Ambrose, one of about 1,000 affected patients, says the drug should be made available on the NHS
https://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.png00BBC Newshttps://alivehealthcareint.co.uk/wp-content/uploads/2024/03/weblogo.pngBBC News2024-10-18 00:39:282024-10-18 00:39:28Breast cancer patients denied life-extending drug in cost row